BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Mar 27, 2026; 18(3): 115888
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.115888
Table 1 Comparison of preoperative baseline data between two groups, n (%)/mean ± SD

T-tube group (n = 32)
Non-T-tube group (n = 36)
t/χ²
P value
Age (years)65.07 ± 9.8963.90 ± 7.640.517> 0.05
Sex
Male13 (40.63)16 (44.44)-0.101> 0.05
Female19 (59.38)20 (55.56)
Body mass index (kg/m2)22.63 ± 2.2922.52 ± 2.700.173> 0.05
Hypertension12 (37.50)14 (38.89)0.014> 0.05
Diabetes8 (25.00)6 (16.67)0.720> 0.05
Tumor
Benign13 (40.63)17 (47.22)0.299> 0.05
Malignancy19 (59.37)19 (52.78)
Bilirubin (μmol/L)63.27 ± 81.3738.72 ± 41.651.839> 0.05
Biliary diameter(mm)5.63 ± 2.055.91 ± 1.21-0.675> 0.05
Table 2 Postoperative complications and hospital stay, n (%)/mean ± SD

T-tube group (n = 32)
Non-T-tube group (n = 36)
F/χ²
Odds ratio (95%CI)
P value
Biliary stricture0 (0.00)8 (22.22)-19.386 (1.071-350.979)< 0.05
Biliary leakage0 (0.00)9 (25.00)-22.455 (1.249-403.547)< 0.05
Biliary bleeding1 (3.12)5 (13.89)1.285> 0.05
Abdominal infection2 (6.25)3 (8.33)0.019 > 0.05
Pulmonary infection3 (9.38)8 (22.22)1.223> 0.05
Days (days)21.97 ± 5.1225.47 ± 5.93-2.714< 0.05
Table 3 Intraoperative parameters, n (%)/mean ± SD

T-tube group (n = 32)
Non-T-tube group (n = 36)
t/χ²
P value
American Society of Anesthesiologists class
II22 (68.8)25 (69.4)0.004> 0.05
III10 (31.2)11(30.6)
Time (minutes)189.94 ± 48.67197.44 ± 20.72-0.749> 0.05
Blood loss (mL)157.81 ± 58.35165.00 ± 51.49-0.496> 0.05
Table 4 Postoperative serum total bilirubin levels, mean ± SD

T-tube group (n = 32)
Non-T-tube group (n = 36)
t/χ²
P value
1st day after operation56.65 ± 166.7836.47 ± 35.541.677> 0.05
5th day after operation44.90 ± 52.9425.95 ± 22.822.179> 0.05
10th day after operation27.38 ± 30.4719.61 ± 14.221.550> 0.05